(Q34034858)

30 July 2017

1 reference

title

Management of familial breast cancer risk (English)

1 reference

30 July 2017

Goodwin PJ

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Breast Cancer Research and Treatment

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

19-33

1 reference

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Efficacy of screening mammography. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Benefits and risks of screening mammography for women in their forties: a statistical appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Positive predictive value of screening mammography by age and family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Screening women aged less than 50 years with a family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Current status of digital mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Future directions in imaging of breast diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Randomized trial of breast self-examination in Shanghai: methodology and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450,000 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast self examination and breast cancer stage at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Mass screening for breast cancer: comparison of the clinical stages and prognosis of breast cancer detected by mass screening and in out-patient clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Results from a seven-year programme of breast self-examination in 89,010 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast self examination and survival from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast self-examination: clinical results from a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

BRCA-associated breast cancer in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Subcutaneous mastectomy data: a final statistical analysis of 1500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Prophylactic mastectomy--the price of fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Cohort studies of fat intake and the risk of breast cancer--a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Fat, caloric intake, and obesity: lifestyle risk factors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Diet, body size, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Screening by mammography, women with a family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Association of Dietary Intake of Fat and Fatty Acids With Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

A Prospective Study of Folate Intake and the Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Update on breast cancer susceptibility genes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Unusual case of Smith-Lemli-Opitz syndrome "type II"

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Randomized study of mammography screening — preliminary report on mortality in the stockholm trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Mammography versus clinical examination of the breasts

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

BRCA2 research is on a fast track to the clinic

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Finding BRCA1's function: a more arduous journey

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

1 reference

7 January 2021

Breast self-examination

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Breast self-examination and survival from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Breast self-examination and survival from breast cancer: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Breast self-examination in relation to the occurrence of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

The effects of breast self-examination in a population-based cancer registry. A report of differences in extent of disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Subcutaneous mastectomy: current state of the art

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Nutrition and breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Summary of the workshop: Workshop on Physical Activity and Breast Cancer, November 13-14, 1997

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006470206271

7 January 2021

Identifiers

DOI

10.1023/A:1006470206271

1 reference

Dimensions Publication ID

30 July 2017

1003558604

0 references

1 reference